NEW YORK — Israeli diagnostics firm Todos Medical said today that it has signed a binding term sheet for the distribution of its TM-B1 and TM-B2 early breast cancer detection blood tests in certain Asian and North American markets.
NEW YORK — Israeli diagnostics firm Todos Medical said today that it has signed a binding term sheet for the distribution of its TM-B1 and TM-B2 early breast cancer detection blood tests in certain Asian and North American markets.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.